Oncology

New test identifies BRCA2 gene mutations that lead to cancers

Researchers at the Mayo Clinic, US, have developed a new test that shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. Dr Fergus Couch, lead author of the study, said: “Certain inherited mutations in the BRCA2 gene have been linked to breast...

Body shame ‘stopping young women attending cervical cancer screening’

Young women are too embarrassed to attend smear tests because of their body shape, the appearance of their genitals and concerns over smelling “normally”, according to a new survey by Jo’s Cervical Cancer Trust, UK. The survey of women aged between 25 and 35 found that 35 per cent...

Two new breast cancer genes discovered

Researchers have discovered two new breast cancer genes, which approximately double a woman’s risk of developing breast cancer by the age of 60. The genes - MSH6 and PMS2 - were discovered by researchers at Columbia University Irving Medical Center and New York-Presbyterian Hospital, US...

Population screening for breast and ovarian cancer mutations ‘is cost-effective’

Screening the entire population for breast and ovarian cancer gene mutations, not just those at high-risk of carrying the mutation, is cost-effective and could prevent more cancers. This is according to research carried out by the Barts Cancer Institute at Queen Mary University of London and Barts...

Hormonal breast cancer therapy linked to chronic disease

Women who have received hormonal therapy for breast cancer face a higher risk of developing chronic conditions in later life, according to new research. Led by the University of South Australia (UniSA), the study found that breast cancer survivors who had received hormonal cancer treatment...

BRCA gene does not alter breast cancer survival rates

Young women diagnosed with breast cancer who carry a BRCA mutation have the same chances of survival as women without the mutation after undergoing treatment. This is the finding of a prospective cohort study led by the University of Southampton, UK. BRCA mutations occur in either the BRCA1 or...

Immune cells ‘play role in breast cancer before tumour develops’

Normal immune cells - known as macrophages - which reside in healthy breast tissue surrounding milk ducts have been discovered to play a major role in helping early breast cancer cells leave the breast for other parts of the body. This then potentially creates metastasis before a tumour has even...

Blueberry extract could boost cervical cancer treatment

Combining blueberry extract with radiation therapy can increase its effectiveness in treating cervical cancer. This is according to new findings from University of Missouri School of Medicine, US, researchers, who studied in vitro human cancer cells. Study lead author Dr Yujiang Fang, visiting...

Study: Cervical cancer incidences to rise in older women

The incidence of cervical cancer in young women is set to fall by 75 per cent by 2040, with deaths close to zero, says new research. However, older women will face greater risk of the disease, according to a study led by Queen Mary University of London, UK. According to the research, women aged...

Many women ‘do not feel informed about breast cancer treatment options’

Most women who have undergone breast cancer operations report not feeling completely informed about their treatment options, according to new research. The researchers - from a number of US institutions - said many patients describe the process of making a treatment decision as “worrisome...